ReviewPain and therapy2026
Neuraxial Medication Administration Errors During Anaesthesia and Perioperative Management, Consequences, Contributing Human and Systemic Factors and Their Prevention: A Systematic Review.
Review in Pain and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis systematic review aimed to investigate neuraxial administration errors, examine their contributing factors, and evaluate clinical outcomes using a novel harm scale.
methodsThe author searched PubMed, Web of Science, Scopus, EBSCOhost, and Google Scholar for reports from 1981 to 2025 in any language. Exclusions were reviews, overdose incidents, and non-neuraxial administrations. Harm was classified using a novel five-level scale, and contributing factors were identified using the Human and Systemic Factors Analysis Classification System (HFACS).
resultsThe search revealed 50 reports (54 patients), mainly involving the epidural route (38 vs 16 intrathecal), non-obstetric patients (35 vs 17 obstetric), and female gender (73%). Medications were grouped into nine divisions: IV fluids/total parenteral nutrition/insulin, anticholinergics, antiseptics, antiemetics, anticoagulants, non-steroidal anti-inflammatory drugs, opioids, Syntocinon, and others. Atropine (6 patients) was the most common, followed by remifentanil (4), Syntocinon (4), chlorhexidine (3), and water (3). Level 4 events (irreversible paraplegia or quadriplegia, 4 patients) and level 5 events (death, 4 patients) were mostly due to accidental antiseptic bolus administration. Inadvertent neuraxial drug administration occurred at different locations and during various stages of clinical care. The Human Factors Analysis Classification System (HFACS) identified unsafe acts related to skill-based errors and misidentification of routinely used objects. Additional deficiencies included organisational processes, resources, supervision, and task execution for neuraxial anaesthesia or analgesia.
conclusionsLevel 4 and 5 harm was mainly associated with the administration of antiseptic solutions. The HFACS framework-based analysis suggested multiple modifiable institutional and individual deficiencies. Multidisciplinary improvements of organisational safety procedures, relevant preconditions, and neuraxial clinical practices may help prevent these serious incidents.
Indexed as
Identifiers
42842184What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.